Clinical Trial Update: Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin [NA]

View source ↗

Summary

A clinical trial update investigating how basal insulin affects liver fat content and visceral fat mass in overweight and obese patients with Type 2 Diabetes Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal insulin (basal insulin)

Snippet

Sponsor: Fudan University | Conditions: Type 2 Diabetes Mellitus | NA | Status: UNKNOWN